Medical Genome Center revealed. The University of Glasgow has studied hybrid viruses. which is mixed with covid and influenza but just in the lab Revealing that the major vaccine manufacturers are preparing to give birth to 1 needle to cover the whole virus.
27 Oct. 2022 – Genome Medical Center Faculty of Medicine Ramathibodi Hospital Mahidol University The Facebook post states that Worried or not with “Hybrid viruses” are formed by the fusion between two types of virus particles: The “RSV virus” and the “flu virus” have been found to evade the immune system well once morest the influenza virus.
Research team from the University of Glasgow In England, two types of viruses were tested: RSV (Respiratory Syncytial Virus) and influenza viruses Both RNA viruses (Figure 1) were cultured together with the same in vitro cultured lung cells. It appears that instead of both types of viruses competing to infiltrate the cell, there is a chance that another type of virus will follow. As in the case of the 2019 coronavirus, the wall of particles of RSV and influenza viruses was found They are fused with separate genomes. become a new type of hybrid virus Shaped like a palm – the RSV virus looks like a trunk. The leaves are from the influenza virus (Figure 2). The original morphology of the RSV virus particles when viewed through an electron microscope revealed a variety of shapes such as spherical, elongated and asymmetrical. while the influenza virus Most are spherical or elliptical (Figure 3).
In vitro tests revealed that the RSV virus and the influenza virus were hybrids. Access to a wider range of target cells Because the influenza virus is originally transmitted in the upper respiratory tract. such as the cells of the nose, throat and trachea, while RSV invades the lower respiratory tract. bronchial and lung cells which is a major cause of pneumonia in young children and the elderly This leads to hospitalizations and thousands of deaths each year. But in vitro hybrid viruses, if they can spread in humans, are thought to be able to infect the nose, throat, trachea and lungs. RSV, or just one type of influenza virus
Hybrid viruses are able to infect neighboring cells even where there are antibodies to the influenza virus that normally prevent influenza virus infection from entering the cells. Under the microscope, the researchers observed the antibodies attached to the hybrid viral sheath at the site of the influenza virus. But hybrid viruses can also use cortical proteins in neighboring RSV viral segments to bind to the lung surface and infiltrate them anyway. It showed that the hybrid virus particles relied on the antibody-blocking RSV sheath as a trojan horse, leading the influenza virus to evade immunity into cells.
But don’t be so quick to worry. Because we only found the hybrid virus in the University of Glasgow lab. There have been no reports of this type of hybrid virus being found to cause disease in humans.
Major vaccine companies are also ramping up production of a combined mRNA vaccine between the coronavirus. 2019-Influenza-RSV virus as a single-dose injection to young children and the elderly to prevent respiratory infections caused by the virus. Clinical Trial Phase I will begin in late 2022. Preliminary animal data show that it can boost immunity to all three types of viruses at the same time. which is expected to be able to prevent infection with the coronavirus hybrid virus 2019-influenza virus-RSV virus too
Therefore, hybrid viral outbreaks, if occurring in the future, may be difficult to transmit in children who have been vaccinated with the combined vaccine during the coronavirus. 2019-influenza virus-RSV virus
https://www.nature.com/articles/s41564-022-01242-5
https://www.theguardian.com/…/immune-system-evading…
https://www.pharmacytimes.com/…/combination-flu-covid…
